Status:

COMPLETED

Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet

Lead Sponsor:

University of Lausanne

Collaborating Sponsors:

Nestlé Research Center, Vers-chez-les-blanc, Switzerland

Conditions:

Hepatic Steatosis

Eligibility:

MALE

18-30 years

Phase:

NA

Brief Summary

This study will assess * whether coffee consumption protects against fructose-induced hepatic steatosis in healthy humans * whether the protective effect of coffee is dependent on it's antioxidant co...

Detailed Description

Epidemiological studies suggest that coffee consumption improves glucose homeostasis in insulin resistant subjects. An increase in intrahepatic lipids (hepatic steatosis) is highly prevalent in patien...

Eligibility Criteria

Inclusion

  • BMI between 19 and 15 kg/m2
  • less than 30 min physical activity /day
  • habitual coffee consumption less than three cupy /day
  • consumption of caffeine-containing sodas less than 2 servings/day
  • non-smoker

Exclusion

  • consumption of alcohol more than 40g/day
  • presence of metallic foreign bodies
  • history of eye surgery
  • family history of diabetes mellitus
  • history of food intolerance
  • vegetarians

Key Trial Info

Start Date :

February 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2011

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT00827450

Start Date

February 1 2009

End Date

March 1 2011

Last Update

February 24 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre d'investigations cliniques "cardiomet"/ CHUV

Lausanne, Switzerland, CH-1011